// IP Marketing video - START// IP Marketing video - END

Pharmaceutical giant Pfizer close to reach $9b deal with Nestle

Pharmaceutical giant Pfizer close to reach $9b deal with Nestle

PanARMENIAN.Net - U.S. pharmaceutical giant Pfizer is close to reaching a $9 billion deal to sell its infant nutrition business to Nestle, AFP reports citing the Wall Street Journal.

The Journal said Nestle, the Swiss food giant, had apparently beaten out Groupe Danone and Mead Johnson Nutrition, which had considered a joint bid for the business, and that the final deal could be announced next week.

A Pfizer spokeswoman contacted by AFP refused to comment on the report, saying "no decisions have been made at this point" on the sale of the infant nutrition business or an animal health business also set to be auctioned off.

"The animal health and nutrition businesses are highly valued assets, and our decision about strategic options will be driven by value creation and delivering the best after-tax value for our shareholders," she said.

Pfizer has moved to unload peripheral entities in recent months in order to focus on its core medicine business.

In November its patent on the best-selling drug of all time, the cholesterol-lowering medication Lipitor, expired, opening the path to generic competitors for America's most popular medication.

 Top stories
As the National Statistical Service reports, imports to Armenia totaled $803.7 million, registering a 17.9% increase year-on-yea
75.8 million kWh of Armenian electricity have been shipped to the Georgian market in the first quarter of 2017.
The government has made a decision to allocate to Sastex the building of the former regional hospital and the adjacent areas.
He said that his government would also focus on fighting corruption and "eliminating all barriers that impede business from developing".
Partner news